Psychedelic Stocks What’s the Deal with Amanita Muscaria? By Dennis Mutua April 10, 2023 Amanita muscaria (also known as fly agaric) is a type of mushroom with hallucinogenic properties. It is also not listed on any schedule of the Controlled Substances Act (CSA). So of course, people want to make and sell it. But wha...
Psychedelic Stocks Oregon Issues First Psilocybin Licenses. Now What? By Dennis Mutua March 27, 2023 Last week, the Oregon Health Authority (OHA) awarded a pair of psilocybin manufacturer licenses. First two! Congrats to Tori Arbrust of Satori Farms PDX, and Andres Met of Satya Therapeutics, known to many of us from the Oregon ca...
Psychedelic Stocks New Brain Scan Study Reveals DMT’s Profound Impact By Dennis Mutua March 23, 2023 Among the emerging medical uses for MDMA and psilocybin is their relative dimethyltryptamine (DMT). Although a Schedule I drug in the United States, DMT increasingly is the subject of study for its potential efficacy in treating a...
Psychedelic Stocks FREE WEBINAR: Ketamine Regulations & The Future of Therapeutic Psychedelic Medicines By Dennis Mutua March 17, 2023 Click HERE to register for our upcoming FREE Q&A webinar on ketamine regulations and the future of therapeutic psychedelic medicines! In the next few years, the FDA will likely approve drug formulations containing psilocybin a...
Psychedelic Stocks Psilocybin and MDMA — Therapeutic Use Permitted in Australia from July 1st 2023 By Dennis Mutua March 02, 2023 Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. Commonly found in tablet or crystal form, MDMA is a potent psychoactive drug with stimulant properties that produces expe...
Psychedelic Stocks Oregon Psilocybin and The Last of Us (Zombies 😱) By Dennis Mutua March 01, 2023 Our marketing people somehow determined that I should write a piece comparing Oregon’s new psilocybin program with The Last of Us– which is a zombie show about a global pandemic caused by a mass fungal infection. Apparently th...
Psychedelic Stocks Good News for Ketamine Telehealth By Dennis Mutua February 28, 2023 Over the last year and change, I’ve written quite a bit about how the ketamine telehealth industry was in store for a rude awakening when the COVID-19 public health emergency (PHE) declaration ended. My most recent post, entitle...
Psychedelic Stocks Utah Ketamine Clinic Update By Dennis Mutua February 27, 2023 Last summer, my colleague, Ethan Minkin, published a post entitled “Utah Ketamine Clinics Face New Patient Monitoring Law.” The law in question applied a host of new requirements on anesthesia or sedation providers, which crea...